Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population - Concepedia

Concepedia

Publication | Closed Access

Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population

32

Citations

9

References

2012

Year

Massimo Breccia, Paola Finsinger, Giuseppina Loglisci, Vincenzo Federico, Michelina Santopietro, Gioia Colafigli, Luigi Petrucci, Adriano Salaroli, Alessandra Serrao, Roberto Latagliata,

Annals of Hematology

Hematological MalignancySingle-institution Patient PopulationHematologyPharmacotherapyMedicineMyelodysplastic SyndromesDeferasirox TreatmentMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1